Form 4: Biote Corp. Director Stephen Mark Cone Increases Stake with Recent Stock Purchase
SEC Form 4 Filing
Director Stephen Mark Cone of Biote Corp. [BTMD] acquired 38,104 shares of Class A Common Stock at an average price of $3.88 on March 17, 2025, increasing his total holdings to 160,829 shares.
Summary
- On March 17, 2025, Stephen Mark Cone, a director of Biote Corp. [BTMD], purchased 38,104 shares of Class A Common Stock.
- The shares were acquired at a weighted average price of $3.88.
- The purchases were made in multiple transactions with prices ranging from $3.55 to $4.00.
- Following the transaction, Cone's total beneficial ownership of Biote Corp. stock increased to 160,829 shares.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a standard disclosure of a stock purchase by a director. While insider buying can be seen as a positive signal, it's not necessarily a strong indicator of future performance.
Positives
- A director's purchase of company stock can be seen as a positive signal, indicating confidence in the company's future prospects.
Industry Context
This is a routine disclosure related to insider trading. It is common for directors and officers of publicly traded companies to buy and sell shares of their company's stock. These transactions are subject to regulations and must be reported to the SEC.
Stakeholder Impact
- The stock purchase by a director could have a minor positive impact on shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 03/17/2025 | Date of stock purchase transaction |
| 03/18/2025 | Date of signature on the SEC Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.